INRD yields 183.49% · ABBV yields 3.06%● Live data
📍 INRD pulled ahead of the other in Year 1
Combined, INRD + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INRD + ABBV for your $10,000?
Inrad Optics, Inc., together with its subsidiaries, develops, manufactures, and markets crystal-based optical components and devices, custom optical components, and precision optical and opto-mechanical assemblies worldwide. The company provides optical components, optical coatings, and subassemblies; and UV filter optical components for use in critical applications in defense systems, such as missile warning sensors, as well as opto-mechanical design and assembly services. Its optical components include planar, prismatic, and spherical components fabricated from glass and synthetic crystals; and various components consist of large form factor transmission flats, optical windows for airborne applications, multi-element optical assemblies, lenses, mirrors, polarizing optics, prisms, wave plates, and x-ray monochromators. The company also offers laser devices and instrumentation products comprising electro-optic and nonlinear crystal devices for altering the intensity, polarization, or wavelength of a laser beam, as well as other crystal components for use in laser research, in commercial laser systems, and in detection of fast neutrons; and pockels' cells and associated electronics. It also serves corporations in the laser system, process control, and metrology sectors of the photonics industry, as well as the United States Government, national laboratories, universities, and institutions. The company markets its products through sales, marketing, and customer service teams, as well as through independent sales agents. Inrad Optics, Inc. also exports its products Europe, Israel, and Asia. The company was formerly known as Photonic Products Group, Inc. and changed its name to Inrad Optics, Inc. in 2012. Inrad Optics, Inc. was incorporated in 1973 and is based in Northvale, New Jersey.
Full INRD Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.